ILCA School 2018 · Chair: S. Bellentani - Locarno (Switzerland) 10.00 Risk of cirrhosis and HCC in...
8
BOLOGNA, MAY 18-19 ILCA School 2018 www.ilca-online.org Hot Topics in Clinical Management of Primary Liver Cancer
Transcript of ILCA School 2018 · Chair: S. Bellentani - Locarno (Switzerland) 10.00 Risk of cirrhosis and HCC in...
KEY DATES
ABSTRACT SUBMISSION31 March 2017
EARLY REGISTRATION 5 June 2017
LATE REGISTRATION28 August 2017
ONSITE FEEAs of 29 August 2017
The international multidisciplinary
forum for liver cancer experts
around the latest innovations in
research and care
BOLOGNA, MAY 18-19
ILCA School 2018
www.ilca-online.org
Hot Topicsin Clinical Managementof Primary Liver Cancer
Friday, May 18
09.00 Opening remarks L. Bolondi - Bologna (Italy)
SESSiON 1 THE rOLE OF CirCULaTiNG aNd TiSSUE BiOMarKErS Chair: J. Zucman-Rossi - Paris (France)
09.10 Predicting the development of HCC in liver cirrhosis E. Villa - Modena (Italy)
09.30 Circulating MiRNA for the diagnosis and staging of HCC L. Gramantieri - Bologna (Italy)
09.50 Discussion
SESSiON 2 NaFLd aNd HCC Chair: S. Bellentani - Locarno (Switzerland)
10.00 Risk of cirrhosis and HCC in NAFLD: can be predicted and/or quantified? J.F. Dufour - Bern (Switzerland)
10.20 Genetic factors associated with HCC in NASH L. Valenti - Milan (Italy)
10.40 Recommendations for screening or surveillance for NAFLD E. Bugianesi - Turin (Italy)
11.15 Break
SESSiON 3 diaGNOSTiC diLEMMaS Chairs: R. Golfieri - Bologna (Italy), F. Trevisani - Bologna (Italy)
11.30 Time for new parameters in MRI for the diagnosis of HCC? R. Golfieri - Bologna (Italy)
11.50 LI RADS classification system, the issue of cholangiocarcinoma F. Piscaglia - Bologna (Italy)
12.10 Discussion
12.20 round table debate starting from clinical cases Management of undefined small nodular liver lesion in cirrhosis Chair: L. Bolondi - Bologna (Italy) discussant: M. Cescon - Bologna (Italy), J.F. Dufour - Bern (Switzerland) F. Piscaglia - Bologna (Italy), M. Renzulli - Bologna (Italy)
13.00 Lunch
SESSiON 4 aNTiViraL TrEaTMENT aNd HCC Chairs: P. Andreone - Bologna (Italy), J. Bruix - Barcelona (Spain)
14.00 Treatment of HBV with antivirals and influence on the risk of HCC P. Lampertico - Milan (Italy)
14.20 Risk of development and natural history of HCC arisen in HCV patient with SVR after interferon based treatment S. Bhoory - Milan (Italy)
14.40 Treatment of chronic hepatitis C with IFN-free DAA regimens and risk of HCC M. Colombo - Milan (Italy)
15.00 Strategies for treatment of HCV with DAA after curative HCC treatment I do always treat C. Cammà - Palermo (Italy)
I do not treat M. Reig - Barcelona (Spain)
Sometimes I treat P.R. Galle - Mainz (Germany)
15.45 Discussion
16.00 Break
Friday, May 18
Friday, May 18
SESSiON 5 CHaLLENGES iN CUrrENT SySTEMiC THEraPy FOr HCC Chairs: P.J. Johnson - Liverpool (United Kingdom), L. Rimassa - Milan (Italy)
16.20 Is it possible to compare the multiple treatments tested for HCC? The Network Metanalysis model A. Cucchetti - Bologna (Italy)
16.40 Is efficacy of Sorafenib and Regorafenib predictable? M. Reig - Barcelona (Spain)
17.00 Stopping rules for Sorafenib in the era of Regorafenib P.J. Johnson - Liverpool (United Kingdom)
17.20 Treatment of HCC in Child-Pugh B class F. Trevisani - Bologna (Italy)
17.40 Discussion
18.00 round table debate Management of advanced HCC in patients with comorbidities Case presentations F. Tovoli - Bologna (Italy)
Expert discussants B. Daniele - Benevento (Italy), M. Reig - Barcelona (Spain), F. Trevisani - Bologna (Italy)
18.30 Closure of the day
SESSiON 6 a LOOK iNTO THE FUTUrE OF HCC Chairs: L. Bolondi - Bologna (Italy), J.F. Dufour - Bern (Switzerland)
08.30 The role of Radioembolization J. Ricke - München (Germany)
08.50 New molecular targets for systemic therapy J. Zucman-Rossi - Paris (France)
09.10 Background and clinical perspectives of immune check-point inhibitors P.R. Galle - Mainz (Germany)
09.30 Postprogression survival and design of second or third line trials in 2018 J. Bruix - Barcelona (Spain)
09.50 Recently concluded and ongoing trials for systemic therapy checkpoint of HCC in 2018: current standpoint L. Bolondi - Bologna (Italy)
10.10 Discussion
10.30 Break
SESSiON 7 THE EMErGiNG iSSUE OF CHOLaNGiOCarCiNOMa Chairs: P.J. Johnson - Liverpool (United Kingdom), F. Piscaglia - Bologna (Italy)
10.50 Development of HCC and ICC. Molecular pathways with a perspective of clinical relevance J.C. Nault - Paris (France)
11.10 Indications for surgery M. Cescon - Bologna (Italy)
11.50 Treatment of mass-forming non surgical intrahepatic cholangiocarcinoma L. Rimassa - Milan (Italy)
12.10 Locoregional treatment of non surgical obstructive cholangiocarcinoma of the main bile ducts R. Golfieri - Bologna (Italy)
12.30 Discussion
12.50 Closure of the meeting
SaTUrday, May 19
GENEraL iNFOrMaTiONMEETiNG VENUEAula Magna Nuove Patologie - Pad 5S. Orsola Malpighi Hospital - Via Massarenti, 9 - 40125 Bologna (Italy)The venue is located 10 minutes from Bologna’s city centre.It can easily be reached by means of public transportation system.
airPOrTThe airport is located 10 km from the city centre. The transfer from the airport to the venue and most of the hotels takes around 30 min by taxi and costs around € 20,00; you can also use the airport bus to get to the centre of the town.
C.M.E. CrEdiTSThrough the C.M.E. division of the Ministry of Health, this meeting has been registered as part of the Italian credit system for medical studies. Credit certificates shall be issued only if the participant has successfully attended the whole meeting and his/her professional qualifications meet the requirements for entitlement to the study credits in question. The C.M.E. credit certificate will be issued only after the candidate has completed and returned the assessment questionnaire at the end of the meeting.
LaNGUaGEThe official language of the meeting is English. Simultaneous translation will not be provided.
LiaBiLiTy aNd iNSUraNCEThe organiser is not able to take any responsibility whatsoever for injury or damage involving persons and property during the meeting. Participants are advised to take out their own personal travel and health insurance for their trip.
MEETiNG dOCUMENTS aNd BadGESThe meeting documents should be collected on-site at the registration desk at the venue. Name badges must be worn at all time during the meeting.
CErTiFiCaTE OF aTTENdaNCEThe certificate of attendance will be collected from the registration desk during the last day of the meeting.
COFFEE BrEaKS aNd LUNCHESCoffee breaks and lunches are included in the registration fee.
rEGiSTraTiON FEE (VAT included)iLCa Member: € 250,00iLCa Non-Member: € 275,00residents and doctoral Students: € 90,00
•PleasenotethatILCAdelegateswhohavenotpaidtheirmembershipduesfor2018willnotbe granted the reduced registration fee. To apply for or renew your membership, please visit the membership section on ILCA Website. •AcopyofstudentIDcardoraCertificateofResident/PHDStudentStatusmustbeprovided upon registration.
GENEraL iNFOrMaTiONONLiNE rEGiSTraTiONYou can register to the ILCA School of Liver Cancer 2018 by following the steps on the website:https://www.ilca-online.org/2018-2/
PayMENTPayment can be made by credit card (Visa, MasterCard or Amex) or by bank transfer. Your registration will be confirmed upon receipt of the full payment only.
CaNCELLaTiON aNd rEFUNd POLiCyFor more information, please contact: ILCA School of Liver Cancer c/o MCI Benelux S.A.Boulevard du Souverain 280, 1160 Brussels - BelgiumTel: +32 2 7892345 - Fax: +32 2 7431550 [email protected]
HOTEL rESErVaTiONPlease find below a list of suggested hotels all within walking distance from the venue.Please note that ILCA has not blocked any rooms at a preferred rate for these hotels. Therefore, we recommend booking early to ensure availability. Please contact the hotel directly to make your reservation.
aEMiLia HOTEL ****Distance from the Congress Venue: 350 mAddress: Via Zaccherini Alvisi, 16 - BolognaWebsite: www.aemiliahotel.itTel.: +39 051 3940311E-mail: [email protected]
HOTEL BLUMEN ***Distance from the Congress Venue: 750 mAddress: Via Mazzini, 45 - Bologna Website: www.hotelblumen.itTel.:+39 051 344672E-mail: [email protected]
HOTEL PEdriNi ***Distance from the Congress Venue: 850 mAddress: Str. Maggiore, 79 - Bologna Website: www.hotelpedrini.itTel.: +39 051 300081E-mail: www.hotelpedrini.it/contatti/
HOTEL BEST WESTErN SaN dONaTO ****Distance from the Congress Venue: 1,3 kmAddress: Via Zamboni, 16 – Bologna Website: www.hotelsandonato.itTel.: +39 051 235395E-mail: [email protected]
arT HOTEL COMMErCiaNTi ****Distance from the Congress Venue: 1,8 kmAddress: Via Dè Pignattari, 11 - BolognaWebsite: www.art-hotel-commercianti.comTel.: +39 051 7457511E-mail: [email protected]
HOTEL rOMa ***Distance from the Congress Venue: 1,8 kmAddress: Via Massimo D’Azeglio, 9 - BolognaWebsite: www.hotelroma.bizTel.: +39 051 231330E-mail: [email protected]
aCKNOWLEdGEMENTThe ILCA School of Liver Cancer 2018 is an initiative organised thanks to an unrestricted educational grant from Bayer HealthCare.
SCiENTiFiC dirECTOrSProf. Luigi Bolondi, Prof. Fabio PiscagliaUnit of Internal Medicine Department of Medical and Surgical SciencesUniversity of Bologna - Alma Mater Studiorum S. Orsola Malpighi Hospital Via Albertoni, 15 - 40125 Bologna (Italy)[email protected] - [email protected]
OrGaNiSiNG SECrETariaTinternational Liver Cancer association (iLCa) Boulevard du souverain, 280 - B-1160 Brussels (Belgium)Tel: +32 2 7892345 - Fax: +32 2 7431550 [email protected] - www.ilca-online.org
LOCaL SECrETariaTFC EVENTi S.r.L.Vicolo Posterla, 20/2a - 40125 Bologna (Italy)tel. +39 051 236895 - fax +39 051 [email protected] - www.fc-eventi.com
